Literature DB >> 9149986

Skin replacement in Dupuytren's disease.

P N Hall1, A Fitzgerald, G D Sterne, A M Logan.   

Abstract

We have reviewed 90 rays in 67 patients who had undergone radical digital dermofasciectomy. Follow-up was from 24 to 100 months. Problems with skin grafts, moving two-point discrimination and active range of joint movement were noted. The recurrence rate in this series was 8%, a very much better figure for disease control than has been reported for standard approaches for Dupuytren's disease. Radical digital dermofasciectomy is strongly recommended for all cases of recurrent Dupuytren's disease requiring reoperation and as a primary procedure when there is significant skin involvement.

Entities:  

Mesh:

Year:  1997        PMID: 9149986     DOI: 10.1016/s0266-7681(97)80061-7

Source DB:  PubMed          Journal:  J Hand Surg Br        ISSN: 0266-7681


  13 in total

Review 1.  Dupuytren's contracture unfolded.

Authors:  W A Townley; R Baker; N Sheppard; A O Grobbelaar
Journal:  BMJ       Date:  2006-02-18

Review 2.  [Treatment of recurrent Dupuytren's disease].

Authors:  T Pillukat; L Walle; R Stüber; J Windolf; J van Schoonhoven
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

Review 3.  Dupuytren's disease: current state of the art.

Authors:  Mark Henry
Journal:  Hand (N Y)       Date:  2014-03

4.  The incidence of postoperative flare reaction and tissue complications in Dupuytren's disease using tension-free immobilization.

Authors:  Michael Rivlin; Meredith Osterman; Sidney M Jacoby; Terri Skirven; Uzoma Ukomadu; A Lee Osterman
Journal:  Hand (N Y)       Date:  2014-12

5.  Skin Graft Review in Dermofasciectomy for Dupuytren's Contracture within 48 Hours: Challenging Historical Practice.

Authors:  Saif Akhter Ansari; James Andrew Kennedy; Fizan Younis
Journal:  J Hand Microsurg       Date:  2021-03-23

6.  Differential gene expression analysis of subcutaneous fat, fascia, and skin overlying a Dupuytren's disease nodule in comparison to control tissue.

Authors:  Barbara Shih; Jason J Brown; Daniel J Armstrong; Tommy Lindau; Ardeshir Bayat
Journal:  Hand (N Y)       Date:  2009-01-29

7.  Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.

Authors:  Linda Vi; Lucy Feng; Rebecca D Zhu; Yan Wu; Latha Satish; Bing Siang Gan; David B O'Gorman
Journal:  Exp Cell Res       Date:  2009-07-18       Impact factor: 3.905

8.  Visual and computer software-aided estimates of Dupuytren's contractures: correlation with clinical goniometric measurements.

Authors:  R P Smith; J J Dias; A Ullah; B Bhowal
Journal:  Ann R Coll Surg Engl       Date:  2009-02-13       Impact factor: 1.891

9.  Seven-year clinical outcomes after collagenase injection in patients with Dupuytren's disease: A prospective study.

Authors:  Rocco De Vitis; Marco Passiatore; Andrea Perna; Silvia Careri; Vitale Cilli; Giuseppe Taccardo
Journal:  J Orthop       Date:  2020-03-29

Review 10.  Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.

Authors:  Catherine Ball; Anna L Pratt; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2013-04-10       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.